ENTA
ENTA clinical trials: ENANTA PHARMACEUTICALS INC
Every trial on ClinicalTrials.gov where ENANTA PHARMACEUTICALS INC is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 46
- Trials linked
- 46
- As lead sponsor
- 0
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
ENTA on the catalyst calendar · ENTA registry changes
- Primary completion Jul 2029Sponsor estimatePhase 2/Phase 3NCT07908381A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe...Enanta Pharmaceuticals, Inc · RSVRecruitingENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 23, 2025ActualPhase 2NCT05568706A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.Enanta Pharmaceuticals, Inc · RSV InfectionCompletedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimatePhase 2NCT07482657A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With...Enanta Pharmaceuticals, Inc · RSV InfectionRecruitingENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2026Sponsor estimatePhase 1NCT07540910A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in...Enanta Pharmaceuticals, Inc · Chronic Inducible UrticariaRecruitingENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 17, 2024ActualPhase 2NCT06170242A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge ModelEnanta Pharmaceuticals, Inc · RSV InfectionCompletedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2, 2025ActualPhase 1NCT06601192A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy AdultsEnanta Pharmaceuticals, Inc · RSV InfectionCompletedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 19, 2024ActualPhase 2NCT04816721A Study to Evaluate EDP 938 Regimens in Children With RSVEnanta Pharmaceuticals, Inc · Respiratory Syncytial Virus (RSV)CompletedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 6, 2025ActualPhase 1NCT06917508A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy ParticipantsEnanta Pharmaceuticals, Inc · RSV InfectionCompletedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 24, 2025ActualPhase 1NCT06847464A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics...Enanta Pharmaceuticals, Inc · RSV InfectionCompletedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 31, 2023ActualPhase 2NCT04633187Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory TractEnanta Pharmaceuticals, Inc · Respiratory Syncytial Virus InfectionsTerminatedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 8, 2023ActualPhase 2NCT05616728A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19Enanta Pharmaceuticals, Inc · COVID-19CompletedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 4, 2022ActualPhase 2NCT04196101A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult SubjectsEnanta Pharmaceuticals, Inc · Respiratory Syncytial VirusCompletedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 29, 2023ActualPhase 1NCT05587478A Study of EDP-323 in Healthy SubjectsEnanta Pharmaceuticals, Inc · RSV InfectionCompletedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 14, 2022ActualPhase 1NCT05594602Drug-Drug Interaction Study Between EDP-235, Itraconazole, Carbamazepine and Quinidine in Healthy Subjects.Enanta Pharmaceuticals, Inc · COVID-19CompletedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 4, 2022ActualPhase 1NCT05594615Drug-Drug Interaction Study Between EDP-235, Midazolam, Caffeine and Rosuvastatin in Healthy SubjectsEnanta Pharmaceuticals, Inc · COVID-19CompletedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 4, 2021ActualPhase 2NCT04378010A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASHEnanta Pharmaceuticals, Inc · Non-Alcoholic SteatohepatitisTerminatedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 20, 2022ActualPhase 1NCT05246878A Study of EDP-235 in Healthy SubjectsEnanta Pharmaceuticals, Inc · SARS CoV 2 InfectionCompletedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 30, 2019ActualPhase 2NCT03691623A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge ModelEnanta Pharmaceuticals, Inc · RSV InfectionCompletedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 4, 2021ActualPhase 1NCT04927793Absorption, Metabolism, and Excretion (AME) Study of [14C]EDP-938 in Healthy Male SubjectsEnanta Pharmaceuticals, Inc · Respiratory Syncytial Virus (RSV)CompletedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 20, 2021ActualPhase 1NCT04971512A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS...Enanta Pharmaceuticals, Inc · Chronic Hepatitis B Virus InfectionTerminatedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 30, 2021ActualPhase 1NCT04470388A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on TreatmentEnanta Pharmaceuticals, Inc · Chronic HBV InfectionCompletedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 14, 2021ActualPhase 1NCT04008004A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2)Enanta Pharmaceuticals, Inc · Chronic HBV InfectionCompletedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 21, 2021ActualPhase 1NCT04559126A Study of EDP-297 in Healthy SubjectsEnanta Pharmaceuticals, Inc · NASH - Nonalcoholic Steatohepatitis With Liver FibrosisCompletedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 27, 2021ActualPhase 1NCT04498741Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy SubjectsEnanta Pharmaceuticals, Inc · RSV InfectionCompletedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 14, 2019ActualPhase 2NCT03421431A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic SteatohepatitisEnanta Pharmaceuticals, Inc · Non-Alcoholic SteatohepatitisCompletedENTALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 21 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner